- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.95B sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.74B sh |
| Capex | Q1 2026 · Mar 31, 2026 | $25M |
| Capex | Q1 2026 · Mar 31, 2025 | $8M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$159M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$142M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $273M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $221M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.96B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.14B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.79B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.88B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $134M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $111M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $221M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $203M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.27B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.32B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.19B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.34B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.11 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.12 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.11 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.12 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $44M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $29M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $195M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $182M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$223M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$208M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$244M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$211M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $6M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $0 |
| Revenue | Q1 2026 · Mar 31, 2026 | $1M |
| Revenue | Q1 2026 · Mar 31, 2025 | $0 |